EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

Overview | Financials
Company Name EyePoint Pharmaceuticals, Inc.
Symbol EYPT
Currency USD
Price 7.33
Market Cap 500,279,830
Dividend Yield 0%
52-week-range 6.9 - 30.99
Industry Biotechnology
Sector Healthcare
CEO Dr. Jay S. Duker M.D.
Website https://eyepointpharma.com

An error occurred while fetching data.

About EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for

Related Stocks

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

3.69 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

3.87 USD

Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc.

ANIK

16.33 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

1.83 USD

Absci Corporation logo

Absci Corporation

ABSI

3.01 USD

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.87 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

1.58 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

0.351 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

4.55 USD

Financials

Numbers are in millions USD

Numbers are in millions USD